Chimeric antigen receptor (CAR) T-cell therapy for blood cancers has numerous poorly-characterised neurologic adverse effects, a new US study shows. A complex pattern of neurotoxicity that can result in headache, confusion, and delirium, is seen in 77% of patients undergoing the novel immunotherapy, according to neurologists and oncologists at Brigham and Women’s Hospital. They evaluated ...
Already a member?
Enter your email to keep reading.